Primary Site >> Colorectal Cancer

Gene >> RPS6

  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.
PMID: 22406476
Ref: mTOR inhibition elicits a dramatic response in PI3K-dependent colon cancers.
PMID: 23593290
Ref: Sym004, a novel EGFR antibody mixture, can overcome acquired resistance to cetuximab.
PMID: 24204198
Ref: Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.
PMID: 23542178
Ref: Phloroglucinol induces apoptosis through the regulation of insulin-like growth factor 1 receptor signaling pathways in human colon cancer HT-29 cells.
PMID: 24970012
Ref: Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.
PMID: 25379021
Ref: Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer.
PMID: 25497009
Ref: Frameshift mutations in mammalian target of rapamycin pathway genes and their regional heterogeneity in sporadic colorectal cancers.
PMID: 25776026
Ref: Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitis.
PMID: 27028006
Ref: Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses.
PMID: 27663511
Ref: Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production.
PMID: 29167573
Ref: High-intensity eccentric training ameliorates muscle wasting in colon 26 tumor-bearing mice.
PMID: 29894511